'Brain fog' after CAR-T? Stanford report links cancer therapy to troubling brain side effects
A groundbreaking
cancer treatment
, known as CAR-T cell therapy, which has been celebrated for its transformative impact on how we treat aggressive cancers, is now coming under critical examination.
Recent research from Stanford University
indicates that this innovative
immunotherapy
might be associated with subtle yet troubling cognitive complications, specifically a phenomenon often referred to as '
brain fog
.' Brain fog encompasses a range of symptoms, including forgetfulness, confusion, and difficulty maintaining focus, all of which can significantly impact a patient's quality of life.
The double-edged sword:
CAR-T therapy
CAR-T cell therapy, or Chimeric Antigen Receptor T-cell therapy, has revolutionized cancer care by empowering a patient's immune system to target and eliminate cancer cells.
This treatment has brought renewed hope to individuals suffering from aggressive forms of blood cancers and even some solid tumors.
However, emerging evidence suggests that the benefits of this therapy may come at a neurological price.
The study, spearheaded by Stanford researchers, revealed that even without chemotherapy or direct brain cancer involvement, CAR-T therapy can lead to mild
cognitive impairment
in some patients.
Unraveling the mechanisms of brain fog
The findings, published in the prestigious journal 'Cell', focused on experiments involving mice that had tumors localized in various sites: some in the brain, others that had metastasized to the brain, and some confined to other areas like bone or skin.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất
IC Markets
Đăng ký
Undo
The researchers conducted a series of cognitive tests before and after the mice underwent CAR-T treatment. Remarkably, cognitive impairment was observed across almost all groups, with the sole exception being the mice with bone cancer, which provoked a minimal immune response outside of the targeted cancer-fighting effects.
What is brain fog?
Brain fog is a term used to describe a range of
cognitive symptoms
that make it difficult to think clearly, focus, and concentrate.
It's often characterized by a feeling of mental sluggishness, confusion, and difficulty recalling information or finding the right words. While not a medical condition itself, brain fog can be a symptom of various underlying causes, including stress, lack of sleep, certain illnesses, or medications.
Dr. Michelle Monje, the study's lead investigator and a pediatric neuro-oncologist at Stanford Medicine, articulated the duality of CAR-T therapy's effects: 'While CAR-T cell therapy holds enormous promise, resulting in long-term survival for patients with aggressive cancers who would otherwise face a dire outcome, it is crucial that we critically assess all potential long-term effects — including the newly uncovered cognitive impairments — to ensure survivors achieve the best possible quality of life.
'
The role of microglia: the brain's immune sentinels
Central to the development of brain fog following CAR-T therapy appears to be microglia, the specialized immune cells that inhabit the brain. The activation of these microglial cells during CAR-T treatment seems to be a key player in the onset of cognitive disturbances, paralleling pathways observed in patients recovering from chemotherapy or respiratory illnesses like COVID-19 and influenza. The independent emergence of cognitive symptoms without the involvement of traditional chemotherapy or other common cancer treatments suggests that CAR-T therapy alone may be capable of inducing these side effects.
A ray of hope for recovery
Despite the implications of these findings, there remains optimism in the research community. The study also pinpointed potential therapeutic avenues aimed at reversing the cognitive impairments linked to CAR-T therapy. By targeting the inflammatory pathways associated with microglial activation, researchers hope to develop new pharmacological interventions that could mitigate or even prevent brain fog in patients recovering from cancer.
As noted by the researchers, 'Innovative therapies that facilitate mental recovery post-immunotherapy could substantially enhance the overall quality of life for survivors.'
The bottom line:
As CAR-T cell therapy gains traction and becomes an integral part of the oncology landscape, these revelations emphasize the necessity of monitoring not just the survival rates but also the long-term cognitive well-being of patients undergoing this treatment. While CAR-T therapy remains a monumental achievement in cancer care, it introduces new dimensions that healthcare providers and researchers must address — ensuring that patients do not merely survive longer, but also thrive in their post-treatment lives.
Sonali Bendre opens up about dealing with after-effects of cancer therapy: I experienced brain fog and couldn't remember things as much in my personal life
One step to a healthier you—join Times Health+ Yoga and feel the change
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
35 minutes ago
- Time of India
UP surpasses nat'l avg in language, math competency for Class 3 students
Lucknow: After taking a big leap forward in the school performance index, UP has made significant strides in learning outcomes. The PARAKH Rashtriya Sarvekshan 2024, which evaluates the effectiveness of the school education system by assessing competencies at various educational stages, shows that Class 3 children in UP have not only improved their performance, but also surpassed the national average. The report shared by the Union Ministry of Education with the state govt shows 68% of Class 3 children in UP are competent in language and 64% in mathematics, while the national average for the two stands at 64% and 60%, respectively. Education officials said in 2021, 55% of Class 3 students were competent in language and mathematics and were below the national average of 59%. According to the document shared by the education department, districts like Kasganj, Shamli, Auraiya, Ambedkar Nagar and Mahoba emerged as top performers in Class 3. The assessment was also carried out for Classes 6 and 9, where steady improvements were visible too. The report shows 55% of Class 6 girls were competent in language against the national average of 57%, while 45% were proficient in mathematics against the national average of 46%. The top-performing districts in the Class 6 category include Kanpur, Shravasti, Kasganj, Shamli and Aligarh. UP also made notable progress in Class 9 results. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Investire è più facile che mai BG SAXO Scopri di più Undo While 38% of students did well in science against the national average of 40%, 34% performed in mathematics against the national average of 37%, and 37% qualified in social sciences against the national average of 40%. Districts such as Varanasi, Kanpur Nagar, Ayodhya, Prayagraj and Shamli recorded the highest performances in Class 9. The pan-India report will be released on July 2. Basic education minister Sandeep Singh said, "UP's performance in the PARAKH National Survey 2024 is a testimony to the fact that when policy, planning, and execution are well-balanced, even the largest states can set benchmarks in education. This is not just a success in numbers, but proof of deep-rooted educational reforms happening at the grassroots level. We are confident that in the coming years, this transformation will become more widespread and robust. "
Time of India
35 minutes ago
- Time of India
72% drop in malaria cases in Bastar from 2015, says admin
Raipur: Bastar division has recorded a 72% drop in malaria cases compared to 2015, under state's disease control programme in one of the most challenging malaria-prone regions, officials said. According to a data released by the state health department, the malaria positivity rate in Bastar has fallen from 4.60% to just 0.46%, while the Annual Parasite Incidence (API) in the region has dropped from 27.4 in 2015 to 7.11 in 2024. At the state level, the API has gone down from 5.21 to 0.98 in the same period. Compared to 2023, malaria cases in 2024 have seen a further decline of 8.52%. Health department officials said that the 10th and 11th phases of the Malaria Mukt Chhattisgarh campaign in 2024 focused on enhanced surveillance and focused treatment, which played a critical role in pushing the numbers down further. The state is conducting the campaign in alignment with guidelines from the National Vector Borne Disease Control Programme (NVBDCP) and the World Health Organization (WHO). Malaria in Chhattisgarh is primarily concentrated in the tribal and forested districts, especially in Bastar division, due to dense forest cover, remote habitations, poor healthcare access, and favourable conditions for mosquito breeding. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo The situation would get tense mostly when a number of security jawans would fall ill or succumb to malaria, after venturing out in forests during monsoon. Frequent incidents of malaria cases among jawans spotlighted the vulnerability of frontline forces and triggered a renewed push for preventive screenings and stricter bed-net enforcement among the troops. CM Sai said that it was a result of community-driven action, consistent fieldwork of health workers, Mitanins, and medical staff. Health minister Shyam Bihari Jaiswal said that the target is to get all districts of Chhattisgarh malaria-free, and sustained efforts are underway to realize this goal. He noted that activities such as distribution of insecticide-treated mosquito nets, door-to-door testing, rapid treatment, and community awareness have been key drivers of this progress.
Time of India
35 minutes ago
- Time of India
‘Inappropriate to claim man intentionally hid disease': Insurance firm ordered to pay
Raipur: The Chhattisgarh State Consumer Disputes Redressal Commission directed an insurance firm backed by a nationalised bank to pay Rs 50 lakh to Savitri Salam, whose husband's insurance claim was initially rejected. The commission found that the insurer failed to conclusively prove concealment of pre-existing diseases by the deceased. Savitri Salam, a resident of Surdongar village in Keshkal tehsil, filed a complaint after her husband's health deteriorated, leading to his demise on 16 June 2021. She sought a claim under a policy taken by her husband, but the insurance firm rejected it, alleging that he provided incorrect information about his pre-existing medical conditions and treatment in the proposal form. The insurance company argued before the district consumer commission that the insured suffered from diabetes and heart disease prior to taking the policy, and this was noted in his medical records from AIIMS, Raipur, as part of his medical history. Based on this, the claim was rejected due to misrepresentation of health information in the proposal form. The District Consumer Commission, Kanker, accepted Savitri Salam's complaint and directed the insurance company to pay the full claim amount within one month. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo The insurance company then challenged this order before the Chhattisgarh State Consumer Disputes Redressal Commission. During the appeal hearing, the bench of Justice Gautam Chourdiya, president, and Pramod Kumar Varma, member, determined that the claim was rejected solely based on a note in the AIIMS, Raipur, medical record. No other medical records were presented to conclusively prove that the insured suffered from diabetes and heart disease before applying for the policy, underwent any prior treatment, or was on continuous medication. The commission observed there was no evidence to suggest that the insured was aware of these conditions when he submitted the proposal. The state commission concluded that it was not appropriate to claim the insured intentionally concealed important facts about his pre-existing diseases in the proposal. The appeal was rejected, and the insurance company has been directed to pay Rs 50 lakh from the life insurance claim, after deducting the Rs 56,621 premium amount already refunded to Savitri Salam by the insurance company. This amount will also include 7% annual simple interest from the date the complaint was filed (27 Dec 2023).
